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Ontogeny of hormonal and excretory function of the meso- and
metanephros in the ovine fetus. Using reverse-transcriptase polymerase
chain reaction (RT-PCR) and immunohistochemistry we investigated the
ontogeny of renin, angiotensinogen and angiotensin converting enzyme(ACE) in the mesonephros at 27 and 41 days of gestation, and the
metanephros at 41 and 64 days of gestation in ovine fetuses (term is 145
to 150 days). The volume and composition of fetal urine, stored as
allantoic fluid were measured in 12 fetuses at 27 days, and 13 fetuses at 41
days. Renin, angiotensinogen and ACE were identified in both meso- and
metanephroi at 41 days but not in the mesonephros at 27 to 30 days.
Allantoic fluid volumes were 21 3 and 45 5 ml at 27 to 30 days and
41 days, respectively. This fluid was significantly different in composition
to that of amniotic fluid or maternal plasma. The results suggest that the
mesonephros can substantially modity its glomerular filtrate by 27 days of
gestation, and can produce local angiotensin II by 41 days.
In mammals the permanent form of the kidney is the metane-
phros, in which each nephron contains a glomerulus, proximal and
distal tubule separated by the loop of Henle, connected to a
collecting duct. This form of the kidney is preceded ontogentically
by a mesonephros, which lacks the loop of Henle [1]. The
mesonephros is the only functional kidney at birth in marsupials
[21 and is the permanent form in fish [3]. For some period of
development both meso- and metanephroi coexist, the metane-
phros continuing to develop, structurally and functionally, as the
mesonephros degenerates. In humans the mesonephros begins to
form at 4 to 5 weeks, is fully developed by the 8th week and is
completely degenerated by 16 weeks, whereas the metanephric
kidney begins to be formed by 5 weeks and remains thereafter as
the permanent kidney [4].
It has been observed that the mesonephros reaches greater
complexity in those species in which an allantoic compartment
forms during development [51. The developmental complexity of
the ovine fetal mesonephros is second only to that of the pig, and
greater than that of cat, rabbit, guinea pig, human and rat [6]. This
is based on (a) the total number of nephrons (34 man, 100 sheep)
and (b) the length of each nephron (1.5 mm in humans, 8 mm in
sheep) and complexity of the glomerulus.
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The mesonephros in the ovine fetus becomes functional at the
23 to 29 somite stage (16 to 18 days of gestation), by which time
the glomeruli are connected to the dorsal aorta and there is a
patent Woiffian duct open to the cloaca [6—8]. The ovine meso-
nephros has its maximal number of nephrons (" 100) by 27 to 30
days of gestation, and slowly regresses over the period of 40 to 57
days of gestation. The first budding of the metanephric duct
occurs about day 27 to 30 in the ovine fetus, as demonstrated in
this report.
In the human embryo, prior to four weeks post-conceptional
age, the allantoic canal is formed from a diverticulum of the
vitelline sac, ultimately opening into the upper part of the cloaca.
The canal is normally obliterated by the 12th week of gestation
and is now known as the urachus, stretching from the apex of the
bladder to the umbilicus [9]. In other species (pig, sheep, etc.) the
allantois extends into the uterine cavity via the umbilical cord (the
umbilical segment is now known as the urachus) and an allantoic
compartment forms, filled with fluid [10]. The origin of this fluid
is fetal urine. After mid-gestation, in the sheep, the composition
of allantoic fluid and fetal urine differ quite significantly, and must
be influenced by differential rates of removal of various solutes
across the allantoic membrane [11]. However, it has been gener-
ally held that the rate of allantoic fluid accumulation early in
pregnancy reflects the rate of urine flow, and an examination of its
composition may give an insight into the functioning of the fetal
kidney.
A strong case has been made that in the fetus the renin-
angiotensin system is essential for the formation of normal
volumes of urine. This argument is based on the association of
neonatal renal failure or oligohydramnios in women treated with
inhibitors of angiotensin-converting enzyme that were presumed
to cross the placenta [12]. Experimental studies in sheep showed
that long-term (days) treatment of pregnant ewes or their fetuses,
late in gestation, with captopril (an ACE inhibitor) decreased
fetal glomerular filtration rate to the point where some fetuses
became anuric. These effects were reversed by infusing angioten-
sin II into the fetus [13].
Although there is some evidence that developing rat kidneys
can produce angiotensin IT independently of renin and ACE [141,
developing kidneys of various species have been shown to contain
cells immunoreative for renin, angiotensinogen and ACE [15—18].
Renin has been claimed to be made by the mesonephros of the
porcine [18] and human fetuses [14].
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Table 1. Primer/probe sequences for RT PCR and southern blots for
angiotensin converting enzyme (ACE), angiotensinogen (Ao), and renin
Primer Sequence
5' AAAGCTCACGAAGTACCTGA
GTCCGCCTGGGACTTCTACA
ATGGGGTCACATVFGGGACGTGAAA'TTFGG
TCACTAGACTFGTCCACGGA
ATCTFCCAGCACAAC'TTCCT
AGCATGGGCACCGGCACTGAAGTGGTGYT'G
TACTATGGTGAGATCGGCATCGGCACCCCA
CCACAGACCTFCAAA
reverse CGCCCCCTAGCAAGTGGGAAT
probe CCTGTGAGATTCACAGCCTCTACGACTCCC
eDNA ATCTGGTIACAGTFCACGACATATTCATCTAT
GCTGAGCT
RNA extraction—PCR
In this study we have examined the endocrine and excretory
capacities of the ovine mesonephros at two stages in early
gestation: 27 to 30 days, when no metanephros has formed; and 40
to 41 days when both meso- and metanephroi are present
simultaneously. Term in the sheep is 145 to 150 days.
Methods
Animals
Pregnant Merino ewes, of known mating date, were killed with
an overdose of pentobarbitone sodium, (100 mg/kg body wt
Lethabarb; Arnolds, Reading, UK) after a sample of venous blood
had been collected by venipuncture.
In group A, 12 ewes, carrying singleton fetuses, were 27 to 30
days pregnant, and in group B, 11 ewes, carrying 13 fetuses, were
40 to 41 days pregnant. For group A the uterus was opened
carefully, and the fetus within the amniotic membrane removed.
Any amniotic fluid present (< 1 ml) was removed with a 1 ml
syringe and 23 gauge needle, the amnion removed and the whole
fetus fixed in a solution of 4% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.2, for 24 hours at room temperature. A
sample of allantoic fluid was collected, and the total volume
measured carefully in a graduated cylinder.
The amniotic and allantoic fluids of fetuses in group B were
sampled and the volumes measured. The organs of 11 fetuses in
group B were removed as follows. Under the dissecting micro-
scope mesonephroi and metanephroi were identified and taken
immediately into separate tubes containing RNA extraction solu-
tion (see below) or into fixative as for the whole group A fetuses.
Pairs of mesonephroi/metanephroi from seven fetuses were used
for RNA extraction, as was a single mesonephros/metanephros
from an eighth fetus. Some of this RNA was used for the
measurement of erythropoietin niRNA, as described elsewhere
[l9J. The other mesonephros/metanephros from this fetus was
fixed for immunohistoehemistry, as were the paired sets of both
kidneys, from three other fetuses, in 4% paraformaldehyde in
phosphate buffer (pH 7.2) for four hours. The organs were washed
in phosphate buffer for eight hours, dehydrated in alcohol and
embedded in paraffin. Two entire fetuses of group B were fixed
whole for dissection and photography. The lungs and livers were
dissected from 11 fetuses in group B, and the brain tissue
aspirated with a 23 gauge needle attached to a 2 nil syringe. These
tissues were frozen immediately in liquid nitrogen for subsequent
RNA extraction.
The mesonephroi and metanephroi were taken into 1 ml of
solution D, containing 4 M guanidinium thiocyanate, 25 mivi
sodium citrate (pH 7.0) 0.5% sarcosyl, 0.1 M 2-mercaptoethanol
and homogenized, at room temperature, with a glass Teflon
homogenizer [20]. The mixture was transferred to a 4 ml polypro-
pylene tube, to which were added 0.1 ml of 2 M sodium acetate
(pH 4), 1 ml of phenol (water saturated) and 0.2 ml of a
chloroform-isoamyl alcohol mixture (49:1) and mixed thoroughly.
The final suspension was shaken vigorously for 10 seconds and
cooled on ice for 15 minutes, then centrifuged at 10,000 g for 20
minutes 4°C. After centrifugation the aqueous phase, containing
the RNA, was tranferred to a fresh tube, mixed with 1 ml of
isopropanol and left at —20°C for at least one hour to precipitate
the RNA. The mixture was then centrifuged at 10,000 g for 20
minutes at 4°C. After centrifugation the aqueous phase, contain-
ing the RNA, was transferred to a fresh tube, mixed with I ml of
isopropanol and left at —20°C for at least one hour to precipitate
the RNA. The mixture was then centrifuged at 10,000 g for 20
minutes, and the resulting pellet dissolved in 0.3 ml of solution D,
transferred to a 1.5 ml Eppendorf tube and precipitated with I vol
of isopropanol at —20°C for one hour. After centrifugation for 10
minutes at 4°C the RNA pellet was removed, resuspended in 75%
ethanol, sedimented, vacuum dried (15 mm) and dissolved in 50
.tl of 0.5% SDS for 10 minutes.
From lung, brain and liver tissue RNA was isolated by homog-
enization in 5 M guanidinium thiocyanate followed by ultracen-
trifugation through a 5.7 M CsCl cushion [21]. RNA was isolated
from tissues of ovine fetuses at 64 days of gestation, collected in a
separate study [111 to provide additional comparisons.
Reverse transcriptionlPCR
eDNA was made from 5 to 10 jg of total RNA by incubation of
the RNA with 3 U of AMV reverse transcriptase (Prom ega) in 25
1.d of 50 mvi KCI, 20 mrvi Tris-HCI (pH 8.4), 50 to 100 pmol
specific primer, and 0.4 mrvi dNTPs at 37°C for 60 minutes.
Reagent blanks were used for the controls. A 10 jrl aliquot of the
RTAse reaction was used for PCR. Amplification was carried out
for 40 cycles in a Perkin Elmer Cetus DNA thermal cycler (1 mm
denaturation at 94°C, 1 mm annealing at 55°C, and 1 mm
extension at 72°C) in 50 pi of 50 niM KCI, 20 mM Tris-HCI (p1-I
8.4), 1.5 mrvi MgCI2, 50 pmol of appropriate primers, and 1.5 U of
Taq polymerase (Gibco). A 10 ftl aliquot of the reaction mixture
was analyzed on 1% ethidium bromide stained agarose gels.
ACEforward
reverse
probe
AU forward
reverse
probe
Rein forward
Reagents
Bovine serum albumin (BSA), polyvinylpyrrolidine, sodium
dodecyl sulphate (SDS). Tris buffer, Ficoll, and Hepes were all
from Sigma Chemical Co. (St. Louis, MO, USA); deoxy nucleo-
tide triphosphates (dNTP) were from Pharmacia (Milton Keynes,
UK). Guanidinium thiocyanate was supplied by Merck (Darm-
stadt, Germany) and agarose came from Progen Industries Ltd
(Darra, Old, Aust.) and T4 PNK by Promega Corp. (Madison, WI,
USA). [b-32P] nitrocellulose was from Amersham International
(Little Chalfont, Buckinghamshire, UK), and X-ray film was
Kodak (Eastern Kodak Co., New Haven, CT, USA). All other
chemicals were reagent grade: MgCl2-BDH (Merck); EDTA
(Ajax Chemicals Auburn, NSW, Australia), KC1 (Mallinkrodt
Specialty Chemicals Co., Chesterfield, MO, USA).
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Fig. 1. Morphological characteristics of the sheep embiyo/fetus at 27 and 41 days of gestation. A. Sagittal paraffin section of ovine embryo at 27 days of
gestation, stained with hematoxylin and eosin, showing large mesonephros (MS), liver (LV) and the first stage of metanephric (MT) development at
the caudal end. Magnification /10. B. Enlargement of the caudal end to show the ureteric bud (U) which has undergone the first branching (UB) and
is surrounded by metanephrogenic mesoderm (MM fl. Magnification x80. C. At higher magnification it can be seen that there are mesonephric
corpuscles (glomeruli - GL) in a central position, surrounded by proximal tubules (PT) distal tubules (DT) and collecting ducts (CD). Magnification
xlOO.
Fig. 2. Macroscopic view of the arrangement of mesonephros (MS), metanephros (MT)
and gonad (G) in the ovine fetus at 41 days of gestation. Liver and gut have been
removed. The right adrenal gland (Ad) has been dissected from its normal position
overlying the metanephros. A small piece of plasticene and a hypodermic needle
(diam 1.1 mm) have been used to elevate and anchor the organs on the right side of
the fetus.
Sequences of the sheep-specific forward and reverse primers used crated a 520 bp fragment, for angiotensinogen a 389 bp fragment,
for eDNA synthesis, the PCR reaction, and internal probes are and for renin a 465 bp fragment. The priming oligonucleotides for
shown in Table 1. PCR for angiotensin converting enzyme gen- the reverse transcription generation of cDNA for ACE and
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Fig. 3. Bioimaging-analyzer-generated image of
RT-PCR products. A. Angiotensinogen (Ao)
gene expression in lung (L), brain (B), liver
(LV), mesonephros (MS) and metanephros(MT) of a 41 days fetus, and in lung (L), brain
(B), liver (LV) and metanephric kidney (K) of
a 64 days ovine fetus (a typical result obtained
for 3 sets of tissues). Product is 387 bp. B.
Angiotensin converting enzyme (ACE) gene
expression in the same tissues as in A. A 520
hp product was obtained in 3 such experiments.
C. Renin gene expression in each of 3 sets of
mesonephroi (MS) and metanephroi (MT) at
41 days of gestation and the metanephric
kidney (K) at 64 days of gestation. The product
is 465 bp.
angiotensinogen were the respective PCR downstream primers.
For renin and angiotensinogen the primers crossed known in-
trons; had there been any DNA contamination the product would
have been much larger. The gene structure for ovine ACE has not
yet been fully elucidated, so a PCR reaction with genomic DNA as
the template was carried out as a control to ensure that no
product of 520 bp was generated. Nitrocellulose filters from
Southern blots were hybridized with 32P probes at 42°C in 50 mM
Hepes (pH 7.0), 3 X SSC, 0.1% SDS, 0.2% BSA, 0.2% Ficoll,
0.2% polyvinylpyrrolidone, 1 mM EDTA and 50 jig/mi of heat-
denatured herring sperm DNA overnight, then washed in 2 X SSC
at 35°C prior to exposure to X-ray film for one to two hours.
Internal oligonucleotides to be used as probes were prepared by
end-labeling with T4 PNK [22]. Probe sequences are shown in
Table 1.
Immunohistochemistiy
Sections of 4 jim were placed on gelatin-coated slides. Slides
were dewaxed and endogenous peroxidase was inhibited with a
solution of 0.3% hydrogen peroxide in methanol for 30 minutes at
room temperature. Sections were rinsed in 0.1 M phosphate buffer
(pH 7.2) and incubated in 10% normal horse serum (NHS) for 3(1
minutes at room temperature. Primary antibodies against angio-
tensinogen (raised in rabbit, used at 1:2000 as in [18]) and renin
(raised in rabbit, used at 1:1500 as in [231) were diluted with 10%
NHS and phosphate buffer and slides were incubated overnight, at
4°C, in a humidified chamber. Detection of immmunostaining was
carried out by incubating tissue with biotinylated goat anti-rabbit
antibody (Vector Laboratories, Inc., Burlingame, CA, USA) at
1:200 for 45 minutes, followed by avidin horseradish peroxidase
Fig. 4. A and B. Renin irnmunoreactive cells (brown staining) in ovine fetal inesonephros (41 days). Counterstained with hematoxylin. Magnification in
A is XlOO and B is X400. Renin hnmunoreactivity (—*) occurs in walls of small and large blood vessels. C, D. Angiotensinogen-immunoreactive cells
(brown staining) in inesoncphros of ovine fetus at 4 days. Counterstained with hematoxylin. Magnificatioii C x40, D x200. Staining occurs in some,
hut not all proximal tubules (pt). E, F. Calbindin D2n<-imnmnoreactive cells in ovine fetal mesonephros (41 days). Counterstained with PAS.
Magnification E X40, F X200. Calbindin JR occurs in collecting ducts (cd).
'
:T:"T
.. .
. . '.. B.
I..
C 2Ft
-• * j, I,
!' —• S — * . a_ •
.. p\s' •t. -4I0tS''. SI' gS. 4%
-.'Pc.*.d .W
U
I,I
"1 S
, '.4'(.1 •_. c
abt,t
S...,
-
I)
A
K..
... •
A
.
. ".41'
• . •
Fig. 5. A, B. Renin immunoreactive cells (brown staining) are seen, more sparsely, in ovine fetal metanephros (41 days), close to the hilus. Counterstained
with hematoxylin. Magnification A >< 00, B x400. C, D. Angiotensinogen-immunorcactive cells (brown staining) in ovine fetal metanephros (41 days).
Counterstained with hematoxylin. Magnification C x40, D x400. E, F. Calbindin D,SK-IR cells in ovine fetal mctanephros (41 days). Calbindin IR
occurs in collecting ducts (Cd) in ureteric bud derivatives, and in differentiating distal tubule (dt). Counterstained with PAS. Magnification E ><40, F
x400.
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complex, at a dilution of 1:1000 for 45 minutes (Vecstatin; Vector
Laboratories). Diaminobenzidine, at a concentration of 0.5 g/ml,
was used as the chromogen. Sections were counterstained with
Meyer's hematoxylin or periodic acid-Schiff reaction.
To more clearly define the morphological elements of the
immature kidneys the ontogeny and location of calbindin-D2SK
immunoreactivity was also studied. Calbindin-D28K is a vitamin-D
responsive calcium binding protein known to be located exclu-
sively in the distal tubules and collecting ducts of adult kidneys
[241. It has been shown to be expressed, constitutively, in the
developing mouse, in Wolffian ducts of mesonephric kidneys, and
ureteric bud derivatives of the metanephric kidney [25]. The
antibody was a monoclonal antibody to calbindin-D2SK (SWant;
Swiss Antibodies, Bellinzona, Switzerland), which is specific for
the calcium-binding region of the ligand and does not cross-react
with calretinin or other known calcium binding proteins [261. It
was used at a dilution 1:2000.
Negative controls were done with all antibodies, in which the
primary antibody was omitted.
Fluid analysis
Osmolality was measured by freezing point depression in an
osmometer (Advanced Instruments, Needham Heights, MA,
USA) and solutes measured on Synchron CX5 clinical system
(Beckman, Fullerton, CA, USA), as described previously [111.
The coefficients of variation for these measurements of constitu-
ents of amniotic and allantoic fluids and maternal plasma have
been reported previously [111.
Results
Morphology
In the 27- to 30-day-old fetuses the mesonephros forms a long
cylindrical structure (Fig. IA) on either side of the dorsal mesen-
tery apposed anteriorly by the foregut structures (liver, stomach)
and posteriorly by the hind gut structures (urogenital sinus). At
this early stage in development, the mesonephros is well formed
and consists of many segmental glomeruli surrounded by tubules
and embedded in interstitium. At the caudal end of the mesone-
phros (Fig. 1B) the ureteric bud showing the first branch is
embedded in a cap of metanephrogenic mesenchyme. In the
mesonephros the large mesonephric corpuscles occupy a medial
position (Fig. 1C). The proximal tubules are lined with cuboidal
epithelial cells; these often extend into Bowman's capsule. The
brush border is discontinuous due to the presence of numerous
polymorphous cytoplasmic protrusions. There is no loop of Henle
as observed in mammalian adult kidneys (metanephroi). The
distal tubule is characterized by the lack of a brush border, with
the height of cells being variable due to cytoplasmic protrusions.
The cells of the collecting tubule are cuboidal or flat with no
cytoplasmic protrusions. The Wolffian duct is lined by simple
cuboidal cells. The tubules and corpuscles are embedded in a
cellular interstitium containing many small blood vessels. The
mesonephros is limited externally by a single layer of coelomic
mesothelium on its free surface.
By 40 days of gestational age, the arrangement of the mesone-
phros, metanephros and gonad has changed (Fig. 2). The ureteric
bud of the metanephros has branched several times and nephron
induction has begun. The metanephros has begun to migrate
cranially, while the mesonephros begins to atrophy from the
cranial to caudal direction.
RT-PcR
As shown in Figure 3 the genes for angiotensinogen, angio-
tensinogen converting enzyme (ACE) and renin were all ex-
pressed in both the mesonephros and the metanephros of the
41-day-old ovine fetus. Angiotensinogen (Fig. 3A) and ACE (Fig.
3B) were expressed in lung, liver and brain, in addition to both
sets of fetal kidneys. No attempt at quantitation was performed.
Immunohistochemistry
Renin. In fetuses of 27 days no renin immunoreactive (IR) cells
were found in the mesonephros (data not shown). In fetuses at 41
days of gestation there were renin JR cells in both the mesone-
phros and the metanephros. In the mesonephros renin IR cells
were seen in the walls of small and large blood vessels, in
proximity to the glomerulus and the proximal tubules (Fig. 4 A,
B). In the metanephros the renin JR cells were found in the walls
of arteries close to the hilus, where blood vessels enter the kidney
(Figs. 5 A, B).
Angiotensinogen. No angiotensinogen JR cells could be seen in
any tubule of the mesonephros at 27 days (data not shown). At 41
days angioterisinogen JR cells were present in both the metane-
phros and mesonephros. As can be seen in Figure 4 C and D, in
the mesonephros not every proximal tubule segment contained
angiotensinogen IR cells, but many did. In the metanephros (Fig.
5 C, D) only a few proximal tubules showed angiotensinogen JR
cells.
Calbindin. In the mesonephros at 27 days (data not shown), as
well as the mesonephros (Fig. 4 E, F) and metanephros at 41 days
(Fig. 5 E, F), calbindin immunoreactivity was present in collecting
ducts located at the periphery of the mesonephros. In the
metanephros ureteric bud branches as well as collecting ducts
showed calbindin immunoreactivity. In addition, some early dif-
ferentiating distal tubules of the metanephric nephron also
showed calbindin immunoreactivity.
Fluid volume and composition
Amniotic fluid. There is almost no amniotic fluid at 27 to 30
days, but the few measurements made on the available samples
indicate the composition is relatively close to that of the 28 ml of
AF present by 40 to 41 days (Table 2). The amniotic fluid differs
from maternal plasma in having lower concentrations of Na,
Cl ,creatinine, Ca2, P042 ,Mg2' and glucose, and < 1% of the
protein. AF contains fructose, which maternal plasma does not,
and remarkably large concentrations of K'. In all respects AF is
like a transudate of fetal plasma (from older fetuses) excepting for
this high K.
Allantoic fluid. Allantoic fluid is fairly similar at 27 and 41 days
(Table 2), only the volume is half, and osmolality, fructose,
protein, calcium and magnesium are lower at 27 than at 41 days.
Allantoic fluid has much lower Na', K, C1 than AF, but
double the urea, four times the creatinine, and three- to sixfold
the Ca2 and Mg2 of AF.
Discussion
The data presented here show that there is a functional
mesonephros present in the ovine fetus at 27 to 30 days of
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Table 2. Composition of fetal fluids and maternal plasma in sheep
Values are mean SEM. N — 12 (allantoic fluid 27—30 days); 13
8 unless otherwise specified for amniotic fluid at 27—30 days.
gestation, but this mesonephros does not express renin or angio-
tensinogen at levels that can be detected by immunohistochemis-
try. The composition of allantoic fluid present at this time suggests
that the mesonephros is competent to produce a dilute urine in
which certain constituents, such as fructose arc present in con-
centrations greater than expected in fetal plasma (which would be
equivalent to that of amniotic fluid). The concentration of calcium
and magnesium in this allantoic fluid/fetal urine is close to that
found in fetal plasma at older gestational ages, for example, at 70
to 75 days of gestation fetal plasma calcium and magnesium
concentrations are 2.9 1.0 (N = 8) and 1.06 0.5 (N = 8)
mmol/liter, respectively [11], whereas 27 to 30 days allantoic fluid
concentrations of calcium and magnesium are 2.49 0.14 (N =
12) and 0.76 0.07 mmol/liter, respectively. This is consistent
with it being fetal urine from a mesonephric kidney, lacking a loop
of Henle, and unable to reabsorb the bulk of the Mg2 and some
of the Ca2. The very high concentration of fructose is consistent
with it being fetal urine. The sharp increase in protein by 40 days
is consistent with protein being actively secreted into the allantoic
compartment, or being taken up from uterine secretions [271. The
composition of allantoic fluid/fetal urine recorded in this study is
consistent, for those constituents measured by others, with the
results recorded by previous workers [27, 28]. By 41 days the
increase in allantoic fluid osmolality and the relatively low volume
are consistent with some alteration of fetal urine occurring by
selective reabsorption of certain constituents across the allantoic
membrane.
Calbindin-D2SK expression has been observed in the mesone-
phros and metanephros of the chick [29], mouse [301 and rat [311.
When studied in culture the mouse Wolffian duct and ureteric bud
of the metanephros were shown to express calbindin-D,SK consti-
tutively, that is, independently of 1,25 dihydroxy-vitamin D1 [251.
It was present in collecting ducts of the mesonephros at 27 and 41
days of gestation, in the ovine embryo/fetus, and in collecting
ducts and ureteric bud derivatives that had not yet formed
connections with developing nephrons in the 41 day metanephros.
By 41 days some metanephric distal tubules were also positive for
calbindin-D2SK. These structures did not express renin or angio-
tensinogen.
By 40 to 41 days of gestation there is good expression of the
genes for the renin-angiotensin system (RAS)-renin, ACE and
angiotensinogen, which appeared stronger in the mesonephros
than the metanephros, at least for renin and angiotensinogen.
Renin has been detected in the mesonephros of the pig at 29 days
gestation (0.25 gestation) but not until a few days later in the
metanephros [32]. There have been several reports of renin in the
metancphros of early human embryos (5 to 8 weeks; 0.13 to 0.2 of
gestation), in both well-developed renal artery branches and
arterioles invading early S-shaped tubules prior to glomerular
formation [15, 171. Both renin mRNA and immunoreactivity have
been found in the human mesonephros at 30 to 40 days after
conception (P. Corvol and J.M. Gase, personal communication).
Angiotensinogen is produced mainly in the liver in the adult,
but there is also a smaller amount produced in the kidney, brain
and ovary [33]. Whole rat embryos, days E17-E21 divided into
head and body segments, also have been shown to contain
angiotensinogen mRNA [31• The angiotensinogen gene has been
shown to be expressed in the mid-gestation fetal sheep metane-
phros and in the late gestation rat metanephros [18]. In the
present study we have extended these findings to the mesonephros
of the early gestation sheep, and shown also that the lung and
brain as well as the liver express the angiotensinogen gene early in
gestation. The site of production in both meso- and metanephros
is the proximal tubule, as seen in older fetuses of sheep and rat
[18].
ACE activity has been found in the lungs of human fetuses in
the second trimester (weeks 10 to 24) and lungs and kidneys of
late gestation rats [35—37]. Although immature rat kidneys contain
enzymic activity capable of generating angiotensin II from angio-
tensinogen independently of renin and ACE [14], ACE protein
has been detected immunohistochemically in human fetal meta-
nephroi at 11 to 30 weeks gestation [16]. In these studies the ACE
protein occurred both in glomerular endothelial cells and on the
basolateral membranes and primary apical microvilli of early
differentiating proximal tubular cells of the metanephros. We did
not have access to an antibody capable of detecting ACE in the
sheep fetus, hut the mRNA studies show that the gene is
— -
Allantoic fluid Amniotic fluid Maternal plasma
Age days
—
27—30 40—41 27—30 40—41
—
2730 40—41
Volume ml 21 3 45 5 0.5 0.08 (8) 28 + 3 — —
Osmolality mOsm/kg water 220 6 245 3 315 (2) 303 2 305 2 303 2
Na mmoi/iiter 89 2 78 6 144 2(5) 140 0.4 149 ÷ 0.5 150 1
K mmoi/liter 7.2 0.7 3.3 0.6 18.1 1.2 (4) 19.9 0.7 4.6 0.1 5.0 0.1
CL mmoi/liter 56 3 58 6 118 1(5) 128 1 112 0.8 111 2
CO2 mmol/liter 31 1 2t) 2 36 1(5) 29 0.7 25 1 28 I
Urea mmol/iiter 9.3 0.8 10 0.5 6.4 0.2 4.9 + 0.3 5.3 0.5 6.1 0.5
Creatinine p.moi/iiter 45 10 67 6 30 13 15 1 71 3 73 3
Ca2 mmoi/liter 2.49 ÷ 0.14 4.26 0.4 1.23 0.04 1.35 0.04 2.7 0.1 2.9 ÷ 0.1
P042 mmol/liter 1.26 0.1 0.69 0.11 0.07 0.03 0.59 0.04 1.9 0.2 2.2 0.02
Mg2 mmol/liter 0.76 0.07 1.74 + 0.34 0.29 0.02 0.30 0.01 0.76 0.03 0.73 0.03
Glucose mmoilliter 1.8 0.3 2.0 0.5 1.8 0.2 (3) 1.5 0.1 4.1 0.1 4.0 ÷ 0.1
Fructose mmoi/iiter 16 1 36 4 5.4 0.4 (3) 3.3 0.1 0 0
Lactate mmol/liter 3.9 0.3 1.5 + 0.1 3.4 0.03 (3) 2.6 0.1 5.6 0.2 5.6 0.5
Total protein g/liter 0.88 0.3 2.35 ÷ 0.42 0.42 0.39 0.11 t).01 73 1 73 I
(allantoic and amniotic fluid 40 41 days); 11 (maternal plasma 40—41 days), N =
1632 Wintour et a!: Mesonephric function in sheep
expressed in mesonephros, metanephros, lung, brain and liver
early (0.27) in gestation.
In the late-gestation ovine fetus the function of the RAS has
been studied extensively [381. It has been suggested, quite
strongly, that the major function of the fetal RAS is to maintain
glomerular filtration rate (GFR) and thus fetal urine production,
important for the maintenance of an adequate volume of amniotic
fluid [38, 39]. This is based on both the increased incidence of
oligohydramnios, neonatal anuria and increased perinatal mortal-
ity and morbidity associated with the use of ACE inhibitors in
pregnant women [12] and on experimental studies using long-term
ACE inhibitors in experimental animals [13, 40]. The role of the
RAS early in gestation may also be to support GFR, but prelim-
inary results do not support this suggestion. We have recently
shown that mesangial cells of mesonephric and metanephric
glomeruli, at 41 days, do express the mRNA for the "functional"
AT1 receptor (A. Albiston and E.M. Wintour, unpublished data).
However, in some preliminary experiments using a three-day
captopril infusion to the pregnant ewe (and thus to the fetus)
there was no effect on the volume/composition of the allantoic
fluid at 41 days (K. Moritz and E.M. Wintour, unpublished data).
It is tempting to speculate that the RAS may have a different
role in early renal development. Angiotensin II receptors of the
type 2 (AT2) are more common in immature kidneys than AT1
receptors [41—45] and AT2 receptors appear to be involved in
apoptosis [46—481. During renal morphogenesis there is consid-
erable apoptosis in mesenchymal cells of the metanephros, and
the mesonephros undergoes regression after its maximum period
of activity. It would be of great interest to know the distribution of
AT2 receptors in the mesonephros as it begins to regress.
In summary, the genes for renin, angiotensinogen and ACE are
expressed in both mesonephros and metanephros by 40 to 41 days
of gestation. The allantoic fluid found at 27 to 30 days indicates a
functioning mesonephros capable of producing a dilute urine.
Acknowledgments
This work was supported by a Block Grant to the Howard Florey
Institute from the National Health and Medical Research Council of
Australia. The authors thank Professor Felix Beck for assistance in the
dissection of the 41 day fetuses.
Reprint requests to Dr. EM. Wintour, Howard Florey Institute, University
of Melbourne, Parkville 3052, Victoria, Australia.
References
1. ENGLE WD: Development of fetal and neonatal renal function. Semin
Perinatol 10:113—124, 1986
2. NELSoN JE, YUEMIN L, GEMMELL RT: Development of the urinary
systems of the marsupial native cat Dasyurus hallucatus. Acta Anat
144:336—342, 1992
3. DANTZLER WH: Comparative aspects of renal function, in The Kidney:
Physiology and Pathophysiology (2nd Edition), edited by SELDIN DW,
GIEmscH G, New York, Raven Press, 1992, pp 885—942
4. DE MARTINO C, ZAMBONI LL: A morphological study of the mesone-
phros of the human embryo. J Ultrastructure Res 16:399—427, 1966
5. BREMER JL: The interrelations of the mesonephros, kidney and
placenta in different classes of animals. Am J Anat 19:179—209, 1916
6. TIEDEMANN K: The mesonephros of cat and sheep, in Comparative
Morphological and Histochemical Studies, Berlin, Springer-Verlag,
1976, pp 7—119
7. DAVIES DV: The development of the mesonephros of the sheep. Proc
Zool Soc Lond 120:73—94, 1950
8. DAVIES J: Correlated anatomical and histochemical studies on the
mesonephros and placenta of the sheep. Am JAnat 91:263—299, 1952
9. SCHEYE TL, VANNEUVILLE G, AMARA B, FRANCANNET PL, DECH-
ELOTFE P, CAMPAGNE D: Anatomic basis of pathology of the urachus.
SurgRadiolAnat 16:135—141, 1994
10. Wirroup EM, LAURENCE BM, LINGw00D BE: Anatomy, physiology
and pathology of the amniotic and allantoic compartments in the
sheep and cow. Aust VetJ 63:216—221, 1986
11. WINTOUR EM, ALCORN E, MCFARLANE A, M0RITz K, P0T0cNIK SJ,
TANGALAKIS K: Effect of maternal glucocorticoid treatment on fetal
fluids in sheep at 0.4 gestation.AmfPhysio/266:Rtt74—Rtt84, 1994
12. PRYDE PG, SEDMAN AB, NUGENT CE, BARR MJR: Angiotensin-
converting enzyme inhibitor fetopathy. JAm Soc Nephrol 3:1575—1582,
1993
13. LUMBERS ER, BURRELL JH, MENZIES RI, STEVENS AD: The effects of
a converting enzyme inhibitor (captopril) and angiotensin II on fetal
renal function. BrJ Pharinacol 110:821—827, 1993
14. YoslPiv IV, EL-DAHR SS: Activation of angiotensin-generating sys-
tems in the developing rat kidney. Hypertension 27:281—286, 1996
15. CELlO MR, GROSCURTH P, INAGAMI T: Ontogeny of renin immuno-
reactive cells in the human kidney. Anat Embiyol 173:149—155, 1985
16. MOUNtER F, HINGLAJS N, SICH M, GROS F, LACOSTE M, DERIS Y,
ALI-IENC-GELAS F, GUBLER MC: Ontogenesis of angiotensin I con-
verting enzyme in human kidney. Kidney lot 32:684—690, 1987
17. PHAT VN, CAMILLERI JP, BRIETY J, GALTIER M, BAVIERA E, CORVOL
P, MERARD J: Immunohistochemical characterization of renin-con-
taming cells in the human juxtaglomerular apparatus during embryo-
nal and fetal development. Lab Invest 45:387—390, 1981
18. DARBY IA, CONGIU M, FERNLEY RT, SERNIA C, COGHLAN JP:
Cellular and ultrastructural location of angiotensinogen in rat and
sheep kidney. Kidney mt 6:1557—1560, 1994
19. WINTOUR EM, BUTKUS A, EARNEST L, POMPOLO S: The erythropoi-
etin gene is expressed strongly in the mammalian mesonephros. Blood
(in press)
20. CHOMEZYNSKI P, SACCHI N: Single step extraction of RNA using acid
guanidium thiocyanate and phenol-chloroform. Anal Chem 162:156—
159, 1987
21. CHIRGWIN JM, PRZBYALA AE, MACDONALD RJ, RUTTER WJ: Isola-
tion of biologically active ribonucleic acid from sources enriched in
ribonuclease. Biochem 18:5294—5299, 1979
22. SAMBROOK I, FRITSCH EF, MANIATIS T: Molecular Cloning: A Labo-
ratoty Manual (2nd ed). Plainview, Cold Spring Harbor Laboratory
Press, 1991
23. CELLo MR, BALER W, SCHARER L, GREGERSEN HJ, DE VIRAGH PA,
NORMAN AW: Monoclonal antibodies directed against the calcium
binding protein Calbindin D-28 k. Cell Calcium 11:599—602, 1990
24. BINDELS RJ, HARDOG A, TIMMERMANS JA, VAN Os CH: Immunocy-
tochemical localization of calbindin—D2°, calbindinD9K, and par-
valbumin in rat kidney. Contrib Nephrol 91:7—13, 1991
25. DAVIES J: Control of calbindinD2SK expression in developing mouse
kidney. Develop Dynam 199:45—51, 1994
26. BERKA JLA, ALCORN D, COGHLAN JP, FERNLEY RT, MORGAN TO,
RYAN G, SKINNER SL, WEAVER DA: Granular juxtaglomerular cells
and prorenin synthesis in mice treated with enalapril. J Hypertens
8:229—238, 1990
27. BAZER FW: Allantoic fluid: Regulation of volume and composition, in
Fetal and Neonatal Body Fluids: The Scientific Bases For Clinical
Practice, edited by BRACE R, Ross MG, ROBILLARD JE, New York,
Perinatology Press, 1989, pp 135—157
28. WALES RG, MURDOCH RN: Changes in the composition of sheep fetal
fluids during early pregnancy. J Reprod Fert 33:197—205, 1973
29. OPPERMAN LA, Ross FP, HIRSCH G: Appearance during chick
embryogenesis of vitamin D-dependant calcium binding protein (Cal-
bindin-D281<). Bone Miner 9:1—8, 1990
30. SHAMLEY DR, OPPERMAN LA, BUFFENSTELN R, Ross FP: Ontogeny of
calbindinD2SK and ca1bindinD9K in the mouse kidney, duodenum,
cerebellum and placenta. Develop 116:491—496, 1992
31. CHANDLER JS, BUCCI TJ: The ontogenesis of calcium binding protein
in fetal rat kidney. Cell Tiss Res 191:363—365, 1978
32. EGERER G, TAUGNER R, TIEDEMANN K: Renin immunohistochcmistry
in the mesonephros and metanephros of the pig embryo. Histochem
8:385—390, 1984
33. OHKUBO H, NAKAYAMA K, TANAKA T, NAKANISHI S: Tissue distribu-
tion of rat angiotensinogen mRNA and structural analysis of its
heterogeneity. J Biol Chem 261:319—323, 1986
Wintour et a!: Mesonephric function in sheep 1633
34. LEE HU, CAMPBELL DJ, HABENER JF: Developmental expression of
the angiotensinogen gene in rat embryos. Endocrinol 121:1335—1342,
1987
35. WALLACE KB, BAILIE MD, HooK JB: Angiotensin-converting enzyme
in developing lung and kidney. Am J Physiol 234:R141—R145, 1978
36. WALLACE KB, BAILIE MD, HOOK JB: Development of angiotensin-
converting enzyme in fetal rat lungs. Am J Physiol 236:R57—R60, 1979
37. SIM MK, SENG KM: Development of angiotensin converting enzyme
in fetal lung and placenta of the rat and human. C/in Exp Pharmacol
Physiol 11:497—502, 1984
38. LUMBERS ER: Functions of the renin-angiotcnsin system during
development. C/in Exp Pharmacol Physiol 22:499—505, 1995
39. GUIGNARD J-P, GOUYON J-B, JOHN EG: Vasoactive factors in the
immature kidney. Pediatr Nephrol 5:443—446, 1991
40. HAREWOOD Wi, PHIPPARD AF, DUGGIN GG, HORVARTH JS, TILLER
DJ: Fetotoxity of angiotensin-converting enzyme inhibition in primate
pregnancy: A prospective, placebo-controlled study in baboons (Papio
hamadiyas). Am J Obstet Gynecol 171:633—642, 1994
41. SHANMUGAM S, CORVOL P, GASC J-M: Ontogeny of the two angioten-
sin II type 1 receptor subtypes in rats. Am J Physiol 267:E828—E836,
1994
42. SHANMUGAM S, LENKEI ZO, GASC J-M, CORVOL, LLOREN-CORTES
CM: Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the
rat. Kidney mt 47:1095—1100, 1995
43. ROBILLARD JE, PAGE WV, MATFIEWS MS, SCHUTrE BC, NUYT AM,
SEGAR JL: Differential gene expression and regulation of renal
angiotensin II receptor subtypes (AT1 and AT2) during fetal life in
sheep. Pediatr Res 38:896—904, 1995
44. ROBILLARD JE, SCHUTTE BL, PAGE WV, FEDDERSON JA, PROTER CC,
SEGAR JL: Ontogenic changes and regulation of renal angiotensin 11
type 1 receptor gene expression during fetal and newborn life. Pediatr
Res 36:755—762, 1994
45. GRONE H-J, SIMON M, FUCHS E: Autoradiographic characterization of
angiotensin receptor subtypes in fetal and adult human kidney. Am J
Physiol 262:F326—F331, 1992
46. KAKUCHI J, ICHIKI T, KIYAMA S, HOGAN BLM, FoGo A, INAGAMI T,
ICHIKAWA I: Developmental expression of renal angiotcnsin H recep-
tor genes in the mouse. Kidney mt 47:140—147, 1995
47. STOLL M, MEFFERT S, STROTH U, UNGER T: Growth or antigrowth:
Angiotensin and the endothelium. J Hypertens 13:1529—1534, 1995
48. YAMADA T, HORIUCHI M, DZAU VJ: Angiotensin II type 2 receptor
mediates programmed cell death. Proc NatlAcad Sci USA 93:156—160,
1996
